Vylor Inc. Stock Price: Quote, Financials, Forecast & News (VYLR)

Vylor Inc.

VYLR · NYSE

$72.00-$1.331.81%

As of: Oct 6, 1:17 PM

$72.00$0.000.00%

· Vol 4.22K

: $73.33
: $48.04B
Open: —
: —
: $0.00 - $0.00
: $65.00 - $75.00
: —
: —
: 4.18K

About Vylor Inc.

Vylor operates in seeds and crop genetics, developing seed products and a pipeline based on elite germplasm, biotechnology, and gene editing. Its stated growth platforms include licensing, gene editing, hybrid wheat, and biofuels. The business makes money through its seed activities and licensing, although the supplied evidence gives no revenue split by segment or customer detail. Morningstar describes Vylor as a global seeds leader and says it invests around 10% of sales in research and development. Reported financials and operating scale are otherwise unavailable in the supplied evidence.

Notable Price Movement

Weekly movement commentary will appear here once it has been generated for this company.

Stories & Analysis

Stocks Settle Higher as Big Tech Rallies

Barchart · 15h ago Mizuho Initiates Coverage of Vylor at Outperform

Fintel · 19h ago Vylor Replaces Corteva In S&P 500

RTTNews · 4d ago

Symbol: VYLR
Type: Stock
Sector: Consumer Staples
Industry: Farming/Seeds/Milling
Country: North America
Exchange: NYSE

Vylor is an advanced seed and genetics company that has, for more than a century, been focused on delivering groundbreaking innovation to farmers. Anchored in the agriculture industry's most elite germplasm and transformative biotech, Vylor leverages its scientific expertise to deliver next generation technology to help farmers around the world boost yields. With its expertise in advanced science, leading routes-to-market and an expanding licensing business, Vylor drives value and delivers growth for farmers, customers and shareholders - and in doing so, helps feed, fuel and clothe the world.

Key Issues

Bullish view

BofA Securities initiated coverage with a Buy rating and a $78 target, while Public reports an average target of $84.75, supporting a substantially higher valuation view.

Bearish view

StockAnalysis reports a $16.33 average 12-month target from three analysts, far below the other cited targets and indicating material downside in at least one published estimate.

Analyst Consensus

See all

Buy

0 analysts

$72

Current

—

Low

$85

Average

—

High

Average target implies +18.06% versus the current price.

Earnings History

No reported EPS history yet.